---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-174317"
form_type: "8-K"
ticker: "PCVX"
cik: "0001649094"
company_name: "Vaxcyte, Inc."
filed_at: "2024-07-02T23:59:59+00:00"
generated_at: "2026-05-31T23:47:12.027280+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Vaxcyte appoints John P. Furey to Board of Directors, effective July 2, 2024

## Summary
- John P. Furey appointed as Class II director; term expires at 2025 annual meeting.
- Furey received initial stock option valued at $800,000 vested over 36 months; also joins Compensation Committee.
- Annual equity awards of $450,000 (75% option, 25% RSU) and cash retainers of $50,000 board / $7,500 committee.
- Indemnification agreement executed; Furey qualifies as independent director under Nasdaq rules.

## SEC filing metadata
- accession: 0001193125-24-174317
- form_type: 8-K
- ticker: PCVX
- cik: 0001649094
- company_name: Vaxcyte, Inc.
- filed_at: 2024-07-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649094/000119312524174317/0001193125-24-174317-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649094/000119312524174317/d781953d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-174317
- JSON: https://secwatch.observer/filing/0001193125-24-174317.json
- Plain text: https://secwatch.observer/filing/0001193125-24-174317.txt

## Key facts
- Executive change
  John P. Furey was appointed as Class II director at Vaxcyte, Inc..
  - Action: appointed
  - Role: Class II director
  source text: the Board of Directors (the “Board”) of Vaxcyte, Inc. (the “Company”) appointed John P. Furey to the Board as a Class II director, which appointment became effective on July 2, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1649094/000119312524174317/0001193125-24-174317-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.